Semi-Supervised Treatment Effect Estimation with Unlabeled Covariates via Generalized Riesz Regression
By: Masahiro Kato
Potential Business Impact:
Improves medical treatments using extra patient information.
This study investigates treatment effect estimation in the semi-supervised setting, where we can use not only the standard triple of covariates, treatment indicator, and outcome, but also unlabeled auxiliary covariates. For this problem, we develop efficiency bounds and efficient estimators whose asymptotic variance aligns with the efficiency bound. In the analysis, we introduce two different data-generating processes: the one-sample setting and the two-sample setting. The one-sample setting considers the case where we can observe treatment indicators and outcomes for a part of the dataset, which is also called the censoring setting. In contrast, the two-sample setting considers two independent datasets with labeled and unlabeled data, which is also called the case-control setting or the stratified setting. In both settings, we find that by incorporating auxiliary covariates, we can lower the efficiency bound and obtain an estimator with an asymptotic variance smaller than that without such auxiliary covariates.
Similar Papers
Semi-supervised inference for treatment heterogeneity
Methodology
Finds best medicine for each person.
On Efficient Estimation of Distributional Treatment Effects under Covariate-Adaptive Randomization
Econometrics
Improves study results by balancing groups better.
Estimating Treatment Effects Under Bounded Heterogeneity
Econometrics
Finds true average effect even when it changes.